Ronald W. Penczek
CIK: 0001659075
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Elevance Health, Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 12, 2026ELV
Elevance Health, Inc.
Sale(S)Direct369 shares at avg. $403.16$149K - May 19, 2026ELV
Elevance Health, Inc.
Exercise(M)Direct877 shares at avg. $311.48$273K - May 19, 2026ELV
Elevance Health, Inc.
Exercise(M)Direct654 shares at avg. $271.27$177K - May 19, 2026ELV
Elevance Health, Inc.
Sale(S)Direct1.5K shares at avg. $403.13$617K - Mar 3, 2026ELV
Elevance Health, Inc.
Tax Payment(F)Direct37 shares at avg. $284.03$11K - Mar 2, 2026ELV
Elevance Health, Inc.
Award(A)Direct266 shares- - Mar 2, 2026ELV
Elevance Health, Inc.
Tax Payment(F)Direct131 shares at avg. $294.07$39K - Mar 2, 2026ELV
Elevance Health, Inc.
Award(A)Direct426 shares- - Mar 2, 2026ELV
Elevance Health, Inc.
Award(A)Direct1.7K shares- - Mar 10, 2025ELV
Elevance Health, Inc.
Sale(S)Direct443 shares at avg. $415.13$184K - Mar 3, 2025ELV
Elevance Health, Inc.
Tax Payment(F)Direct198 shares at avg. $395.50$78K - Mar 3, 2025ELV
Elevance Health, Inc.
Award(A)Direct285 shares- - Mar 3, 2025ELV
Elevance Health, Inc.
Award(A)Direct421 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 | ELV Elevance Health, Inc. | Sale(S) | 369 | $403.16 | $148,766 | Direct |
| May 19, 2026 | ELV Elevance Health, Inc. | Exercise(M) | 877 | $311.48 | $273,168 | Direct |
| May 19, 2026 | ELV Elevance Health, Inc. | Exercise(M) | 654 | $271.27 | $177,411 | Direct |
| May 19, 2026 | ELV Elevance Health, Inc. | Sale(S) | 1,531 | $403.13 | $617,192 | Direct |
| Mar 3, 2026 | ELV Elevance Health, Inc. | Tax Payment(F) | 37 | $284.03 | $10,509 | Direct |
| Mar 2, 2026 | ELV Elevance Health, Inc. | Award(A) | 266 | - | $0 | Direct |
| Mar 2, 2026 | ELV Elevance Health, Inc. | Tax Payment(F) | 131 | $294.07 | $38,523 | Direct |
| Mar 2, 2026 | ELV Elevance Health, Inc. | Award(A) | 426 | - | $0 | Direct |
| Mar 2, 2026 | ELV Elevance Health, Inc. | Award(A) | 1,701 | - | $0 | Direct |
| Mar 10, 2025 | ELV Elevance Health, Inc. | Sale(S) | 443 | $415.13 | $183,903 | Direct |
| Mar 3, 2025 | ELV Elevance Health, Inc. | Tax Payment(F) | 198 | $395.50 | $78,309 | Direct |
| Mar 3, 2025 | ELV Elevance Health, Inc. | Award(A) | 285 | - | - | Direct |
| Mar 3, 2025 | ELV Elevance Health, Inc. | Award(A) | 421 | - | - | Direct |
1-13 of 13 transactions
About Penczek Ronald W
Penczek Ronald W (SEC CIK 0001659075) files insider reports with the SEC as CAO & Controller of Elevance Health, Inc. (ELV).
Signal8 holds 5 ownership filings by Penczek Ronald W, all Form 4s, filed between Mar 5, 2025 and Jun 15, 2026. Those filings report 13 transactions, from Mar 3, 2025 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Penczek Ronald W's filings is in INDIANAPOLIS, IN.
Recent filings by Penczek Ronald W
- Jun 12, 2026: Open-market sale of ELV shares (Form 4, code S).
- May 19, 2026: Option exercises of ELV shares (2 lines, Form 4, code M).
- May 19, 2026: Open-market sale of ELV shares (Form 4, code S).
- Mar 3, 2026: Tax withholding of ELV shares (Form 4, code F).
- Mar 2, 2026: Grant or award of ELV shares (Form 4, code A).
Other insiders filing for Elevance Health, Inc. (ELV)
- Kaye Mark, EVP & CFO
- Wessling Erin M, EVP & Chief Legal Officer
- Craig Ryan R, EVP & Chief HR Officer
- PERU RAMIRO G, Director
- BOUDREAUX GAIL, President and CEO
- Dixon Robert L JR, Director